IP Library Granted Patent US 9,382,522
Granted Patent B2
US 9,382,522 · App. 12/544,199 · Granted Jul 5, 2016

Patent

Inventors: Elena V. Bolchakova (Union City, CA); James E. Rozzelle (San Francisco, CA)
Assignee: APPLIED BIOSYSTEMS, LLC
C12N9/1252C12P19/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,382,522
App. No.
12/544,199
Granted
Jul 5, 2016
Kind
B2
Abstract

The invention provides nucleic acids and polypeptides for a nucleic acid polymerase from a thermophilic organism, Thermus scotoductus . The invention also provides methods for using these nucleic acids and polypeptides.

Claims (18)

1. An isolated derivative nucleic acid polymerase comprising an amino acid sequence having at least 95% sequence identity to SEQ ID NO:14, wherein said amino acid sequence comprises an Asp in place of Gly at a position corresponding to amino acid position 46 of SEQ ID NO:13, wherein said amino acid sequence further comprises an Arg at a position corresponding to amino acid position 250 of SEQ ID NO:13, and wherein said derivative nucleic acid polymerase has decreased 5′-3′ exonuclease activity compared to a wild type nucleic acid polymerase comprising SEQ ID NO:14.

2. The derivative nucleic acid polymerase according to claim 1 , wherein said derivative nucleic acid polymerase is thermostable.

3. The derivative nucleic acid polymerase according to claim 1 , wherein said amino acid sequence further comprises a Tyr in place of Phe at a position corresponding to amino acid position 668 of SEQ ID NO:13.

4. The derivative nucleic acid polymerase according to claim 1 , wherein said amino acid sequence comprises Val and Arg at positions corresponding to amino acid positions 249 and 250, respectively, of SEQ ID NO:13.

5. The derivative nucleic acid polymerase according to claim 1 , wherein said amino acid sequence comprises Arg and Thr at positions corresponding to amino acid positions 250 and 251, respectively, of SEQ ID NO:13.

6. The derivative nucleic acid polymerase according to claim 1 , wherein said amino acid sequence comprises Val, Arg, and Thr at positions corresponding to amino acid positions 249-251, respectively, of SEQ ID NO:13.

7. An isolated derivative nucleic acid polymerase comprising an amino acid sequence having at least 95% sequence identity to SEQ ID NO:14, wherein said amino acid sequence comprises an Asp in place of Gly at a position corresponding to amino acid position 46 of SEQ ID NO:13, wherein said polymerase further comprises a Pro at a position corresponding to amino acid position 254 of SEQ ID NO:13, and wherein said nucleic acid polymerase has decreased 5′-3′ exonuclease activity compared to a wild type nucleic acid polymerase comprising SEQ ID NO:14.

8. The derivative nucleic acid polymerase according to claim 7 , wherein said derivative nucleic acid polymerase is thermostable.

9. The derivative nucleic acid polymerase according to claim 7 , wherein said amino acid sequence further comprises a Tyr in place of Phe at a position corresponding to amino acid position 668 of SEQ ID NO:13.

10. The derivative nucleic acid polymerase according to claim 7 , wherein said amino acid sequence comprises Leu and Pro at positions corresponding to amino acid positions 253 and 254, respectively, of SEQ ID NO:13.

11. The derivative nucleic acid polymerase according to claim 7 , wherein said amino acid sequence comprises Pro and Leu at positions corresponding to amino acid position 254 and 255, respectively, of SEQ ID NO:13.

12. The derivative nucleic acid polymerase according to claim 7 , wherein said amino acid sequence comprises Leu, Pro, and Leu at positions corresponding to amino acid positions 253-255, respectively, of SEQ ID NO:13.

13. An isolated derivative nucleic acid polymerase comprising an amino acid sequence having at least 95% sequence identity to SEQ ID NO:14, wherein said amino acid sequence comprises an Asp in place of Gly at a position corresponding to amino acid position 46 of SEQ ID NO:13, wherein said polymerase further comprises a Leu at a position corresponding to amino acid position 471 of SEQ ID NO:13, and wherein said nucleic acid polymerase has decreased 5′-3′ exonuclease activity compared to a wild type nucleic acid polymerase comprising SEQ ID NO:14.

14. The derivative nucleic acid polymerase according to claim 13 , wherein said derivative nucleic acid polymerase is thermostable.

15. The derivative nucleic acid polymerase of claim 13 , wherein said amino acid sequence further comprises a Tyr in place of Phe at a position corresponding to position 668 of SEQ ID NO:13.

16. The derivative nucleic acid polymerase according to claim 13 , wherein said amino acid sequence comprises Arg and Leu at positions corresponding to amino acid positions 470 and 471, respectively, of SEQ ID NO:13.

17. The derivative nucleic acid polymerase according to claim 13 , wherein said amino acid sequence comprises Leu and Glu at positions corresponding to amino acid positions 471 and 472, respectively, of SEQ ID NO:13.

18. The derivative nucleic acid polymerase according to claim 13 , wherein said amino acid sequence comprises Arg, Leu, and Glu at positions corresponding to amino acid positions 470-472, respectively, of SEQ ID NO:13.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2015
From: BOLCHAKOVA, ELENA V.; ROZZELLE, JAMES E.
To: APPLERA CORPORATION
Reel/Frame 036281/0020 →
MERGER Recorded Aug 7, 2015
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 036281/0102 →
MERGER Recorded Aug 7, 2015
From: ATOM ACQUISITION CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 036281/0218 →
MERGER Recorded Aug 7, 2015
From: ATOM ACQUISITION CORPORATION; APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 036281/0323 →
Continuity (2)
Division 10799369 · Mar 12, 2004
Related Publication 20100086970A1 · Apr 8, 2010